International survey highlights major gaps in cardio-oncology education
An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance. These results were presented…
Heart failure treatments protect heart function during cancer therapy
The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC…
Proton cancer therapy arrives in Bay Area
Stephen De La Torre, 7, is usually all smiles. But on a recent Wednesday at Stanford Medicine’s cancer…
New spatial map reveals treatment vulnerabilities in bladder cancer
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder…
AI accurately measures mesothelioma tumors for better treatment decisions
Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians at evaluating…
New biomarker predicts gastric cancer outcomes from CT scans
Researchers at the State University of Campinas (UNICAMP) in São Paulo, Brazil, have identified a new biomarker that…
Blood Test Detects HPV-Related Head and Neck Cancer Recurrence Risk
Investigators from Mass General Brigham Cancer Institute have developed an ultrasensitive blood test that identifies patients with human…
Targeted reminders increase serious illness conversations in cancer care
New research in the June 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that small, targeted prompts…
Mesothelioma remains deadly despite declining asbestos exposure rates
Mesothelioma deaths and diagnoses continue to rise in the United States despite decades of asbestos regulation and reduced…
Could GLP-1 drugs help prevent breast cancer? New study points to a possible link
A major breast imaging study links GLP-1 agonists to lower breast cancer incidence, raising hopes for a new…
Novel PRRT approach shows promise in advanced neuroendocrine tumors
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients…
Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with Pluvicto plus standard of…